Kidney Disease, Framingham Risk Scores, and Cardiac and Mortality Outcomes

American Journal of Medicine

Volumn 120, Issue 6, 2007, Pages

  Weiner, Daniel E ^a   Tighiouart, Hocine ^a   Griffith, John L ^a   Elsayed, Essam ^a   Levey, Andrew S ^a   Salem, Deeb N ^a   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Chronic kidney disease; Coronary heart disease; Framingham Risk Score; Renal insufficiency

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SMOKING HABIT;

AFRICAN AMERICANS; AGED; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34248578360     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.05.054     Document Type: Article

References (40)

1. Wilson P.W., Castelli W.P., and Kannel W.B. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 59 (1987) 91G-94G
2. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
3. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
4. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
5. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
6. Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 (2004) 1307-1315
7. The ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129 (1989) 687-702
8. Fried L.P., Borhani N.O., Enright P., et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1 (1991) 263-276
9. Levey, Kusek J.W., and Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. AS GT. J Am Soc Nephrol 11 (2000) 155A (Abstract)
10. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
11. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
12. Weiner D.E., Tighiouart H., Stark P.C., et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 44 (2004) 198-206
13. Shlipak M.G., Fried L.F., Cushman M., et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293 (2005) 1737-1745
14. Merkin S.S., Coresh J., Roux A.V., Taylor H.A., and Powe N.R. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 46 (2005) 203-213
15. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
16. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R., and The Framingham study. Predicting coronary heart disease in middle-aged and older persons. JAMA 238 (1977) 497-499
17. Fried L.F., Katz R., Sarnak M.J., et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16 (2005) 3728-3735
18. Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., and Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
19. Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., and Castelli W.P. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110 (1979) 281-290
20. US Census Bureau. Population by Race and Hispanic or Latino Origin for the United States: 1990 and 2000 Detailed Tables (PHC-T-1). Table 1.1 Population by Race and Hispanic or Latino Origin, for All Ages and for 18 Years and Over, for the United States: 2000. March 12, 2001. Available at: http://www.census.gov/population/cen2000/phc-t1/tab01.xls. Accessed December 7, 2005.
21. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S adults, 1999 to 2000. J Am Soc Nephrol 16 (2005) 180-188
22. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
23. Liu J., Hong Y., D'Agostino Sr. R.B., et al. Predictive value for the Chinese population of the Framingham coronary heart disease risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291 (2004) 2591-2599
24. Empana J.P., Ducimetiere P., Arveiler D., et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations?. The PRIME Study. Eur Heart J 24 (2003) 1903-1911
25. Kalantar-Zadeh K., Block G., Humphreys M.H., and Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 (2003) 793-808
26. Muntner P., He J., Hamm L., Loria C., and Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13 (2002) 745-753
27. Weiner D.E., Tighiouart H., Vlagopoulos P.T., et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 16 (2005) 1803-1810
28. McClellan W.M., Flanders W.D., Langston R.D., Jurkovitz C., and Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 13 (2002) 1928-1936
29. Knight E.L., Rimm E.B., Pai J.K., et al. Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol 15 (2004) 1897-1903
30. Sarnak M.J. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 41 5 Suppl (2003) 11-17
31. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
32. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
33. Schulgen G., Olschewski M., Krane V., Wanner C., Ruf G., and Schumacher M. Sample sizes for clinical trials with time-to-event endpoints and competing risks. Contemp Clin Trials 26 (2005) 386-396
34. Wright Jr. J.T., Bakris G., Greene T., et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288 (2002) 2421-2431
35. Aktas M.K., Ozduran V., Pothier C.E., Lang R., and Lauer M.S. Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA 292 (2004) 1462-1468
36. Peralta C.A., Hicks L.S., Chertow G.M., et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension 45 (2005) 1119-1124
37. Nickolas T.L., Frisch G.D., Opotowsky A.R., Arons R., and Radhakrishnan J. Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis 44 (2004) 185-197
38. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106 (2002) 1777-1782
39. Howard G., Manolio T.A., Burke G.L., Wolfson S.K., and O'Leary D.H. Does the association of risk factors and atherosclerosis change with age? An analysis of the combined ARIC and CHS cohorts. The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health Study (CHS) investigators. Stroke 28 (1997) 1693-1701
40. Wong T.Y., Larsen E.K., Klein R., et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology 112 (2005) 540-547